Florent Cespedes analyst SOCGEN

Currently out of the existing stock ratings of Florent Cespedes, 1 are a HOLD (12.5%), 3 are a SELL (37.5%), 4 are a BUY (50%).

Florent Cespedes

Work Performance Price Targets & Ratings Chart

Analyst Florent Cespedes, currently employed at SOCGEN, carries an average stock price target met ratio of 50% that have a potential upside of 18.32% achieved within 345 days.

Florent Cespedes’s has documented 16 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LLY, Eli Lilly and Company at 16-Feb-2023.

Wall Street Analyst Florent Cespedes

Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 11/3/2020. The price target of $30.79 was fulfilled within 1 day with a profit of $0.83 (2.77%) receiving and performance score of 27.7.

Average potential price target upside

LLY Eli Lilly and Company NVS Novartis AG ADR NVO Novo Nordisk A/S SNY Sanofi ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$1290

$214.53 (19.95%)

$1171

22 days ago
(24-Nov-2025)

33/38 (86.84%)

$219.84 (20.54%)

201

Buy

$1150

$74.53 (6.93%)

$1050

28 days ago
(18-Nov-2025)

30/31 (96.77%)

$119.95 (11.65%)

278

Buy

$1165

$89.53 (8.32%)

$885

1 months 3 days ago
(13-Nov-2025)

47/48 (97.92%)

$176.38 (17.84%)

120

Buy

$1500

$424.53 (39.47%)

$1190

1 months 4 days ago
(12-Nov-2025)

1/4 (25%)

$511.38 (51.73%)

437

Buy

$1080

$4.53 (0.42%)

$895

1 months 6 days ago
(10-Nov-2025)

7/8 (87.5%)

$155.63 (16.84%)

138

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Florent Cespedes?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?